At the 43rd Congress of the European Society for Surgical Oncology (ESSO), three leading experts in breast surgery presented data demonstrating the clinical benefits of The MOZART ® 3D Specimen Radiography System from KUBTEC ® . Dr. Ash Kothari (Guy's Hospital, UK), Dr. Tomasz Sachańbiński (Opole Center for Oncology, Poland) and MUDr. Jan Beneš (České Budějovice Hospital, Czech Republic) shared data from their workplaces showing a consistent trend: the

Motive Health, Inc., the innovative healthcare technology company behind the first FDA-cleared neuromuscular electrical stimulation device for knee pain, has hit an important milestone: its first year as a direct-to-consumer (DTC) brand. The company, which previously offered their prescription-only products under the brand CyMedica Orthopedics, is also celebrating 10 years in business and to-date has helped over 25,000 people combat knee issues with their patented technology. Initia

UnitedHealthcare today announced a $335,000 commitment in funding to Idaho organizations to help close gaps in care among underserved communities, including people in rural areas, individuals with chronic conditions and seniors. “Expanding programs for caregivers, community health workers and providers allows us to address unmet health needs more effectively, helping to ensure that underserved communities access high-quality care and social services they need,” said Dr.

Mainstay Medical announced today that the U.S. Centers for Disease Control and Prevention (CDC) has designated an International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) diagnostic code specifically for multifidus dysfunction in the lower back. The new diagnostic code, M62.85: dysfunction of the multifidus muscles, lumbar region, is effective October 1, 2024. In response to an acute injury to the low back, the brain typically reduces the neural dr

Globus Medical, a leading musculoskeletal solutions company, announces the continued growth and expansion of its orthopedic trauma product portfolio. Globus has introduced several new system extensions so far in 2024 and received 510(k) clearance from the U.S. Food and Drug Administration for its first suture-based product, TENSOR™ Suture Button System. Newly launched, next-generation systems include ANTHEM™ II Distal Radius Volar Plates, AUTOBAHN™ Trochanteric Nai

Baylis Medical Technologies Inc. announced the commercial launch of the PowerWire® Pulse Radiofrequency (RF) Guidewire in the United States. The PowerWire Pulse RF Guidewire is the newest addition to the PowerWire® Family of RF Guidewires and is designed to create a path through soft tissues with controlled RF puncture technology. The 0.035" RF Guidewire features a torquable, stiff proximal shaft for optimal control, while a smooth transition to a more flexible distal e

Thubrikar Aortic Valve, Inc. today announced successful results in an additional 5 patients implanted with the Optimum Transcatheter Aortic Valve (Optimum TAV™) using the Precision 2™ Delivery Catheter. These procedures demonstrated excellent performance of both the valve and delivery catheter, despite the anatomical challenges presented by the patients. Interventional Cardiologist and TAVI-1 CE Mark trial Principal Investigator, Dr. Jaroslaw Trebacz, conducted the proce

Wellinks, the industry leader in virtual-led cardiopulmonary care, announced today it has acquired Spire Health in a non-cash transaction. The acquisition merges Spire’s novel patient monitoring technology with Wellinks highly specialized virtual-led cardiopulmonary care model creating a first of its kind fully integrated Predictive Patient Care company. As part of the agreement, Wellinks welcomes to the board of directors Mr. Rich Wilmot who will represent Spire’s majority invest

ResMed, the world’s leading health technology company focused on sleep, breathing, and care delivered in the home, today announced new patient-centric products designed to enhance the therapy journey for sleep apnea patients. These innovations integrate with digital wearable devices and generative artificial intelligence designed to deliver a more personalized sleep health experience and improve overall health. ResMed’s 2024 Global Sleep Survey found that 44% of American

Consumer Cellular, the most awarded brand for wireless customer service by J.D. Power, has announced the launch of the IRIS Ally, an affordable, easy-to-use, lightweight medical alert device. “The IRIS Ally provides our consumers and their loved ones the freedom to live independently with a little back pocket support,” said Ed Evans, Consumer Cellular CEO. “With the push of a button, users can reach a real human being 24/7, 365 days a year, giving peace of mind whi